Stocktoria
PERRIGO Co plc PRGO
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 1991-12-17
PERRIGO Co plc statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 35.1% | 35.3% | 36.1% | 32.7% | 34.2% |
| Operating margin | -26.4% | 2.6% | 3.3% | 1.8% | 9.9% |
| Net margin | -33.5% | -3.9% | -0.3% | -3.2% | -1.7% |
| FCF margin | 3.4% | 5.6% | 6.5% | 4.7% | 0.1% |
| Return on assets | -16.7% | -1.8% | -0.1% | -1.3% | -0.7% |
| Return on equity | -48.6% | -4.0% | -0.3% | -2.9% | -1.3% |
| Debt / equity | 1.23× | 0.83× | 0.76× | 0.84× | 0.57× |
| Current ratio | 2.76 | 2.38 | 1.79 | 2.44 | 2.43 |
| Revenue growth | -2.8% | -6.1% | 4.6% | 7.6% | 1.2% |
Source: SEC EDGAR filings · CIK 0001585364 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.